Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™

India, 25 November 2021 – Boehringer Ingelheim India, a world-leading, research-driven pharmaceutical company, and market leader in Stroke therapy recently achieved the Guinness World Records title for “Most pledges received for a stroke awareness campaign in one week”. The company’s stroke awareness campaign aimed at driving heightened awareness about stroke, encouraged people to calculate their stroke risk and take a pledge to reach the nearest hospital with neurospecialists and a CT scan facility within 4.5 hours on identifying symptoms of stroke.

The title-winning campaign witnessed great response from hospitals and stroke care specialists, in addition to people across India. Within a week of the campaign launch, 17,691 people participated in a survey to understand their risk of getting Stroke over the next 10 years, whilst pledging to be Stroke- aware and ready to help themselves and others, setting a new Guinness World Record.

According to the Indian Stroke Association (ISA), as many as 18 lakh cases of brain stroke are being reported every year. One of the major reasons behind the increase in stroke incidences has been the lack of awareness around brain stroke, its prevention, and treatment. To draw attention towards brain stroke, Boehringer Ingelheim India, ahead of World Stroke Day, observed on October 29, initiated a week-long awareness campaign, starting October 28-November 03, 2021. Leveraging its in-house expertise of stroke experts, as a part of the campaign, Boehringer Ingelheim India developed a digital Stroke Risk Calculator reference to MyRisk Stroke calculator¹ (McGill University, Montreal), a platform that helped individuals assess their stroke risk in the next 10 years and educate them about brain stroke and its symptoms.

Ms. Vani Manja, Managing Director, Boehringer Ingelheim India, said, “It is heartening to witness the increasing health consciousness of people in India. Their interest to understand disease conditions and therapies, and their focus on remaining healthy and helping those that need support is humbling. This Guinness World Records achievement for Boehringer Ingelheim India is a reflection of people’s increasing participation in healthcare awareness and therapy programmes, with expert support from the Indian healthcare community. The support and partnership we receive from hospitals and healthcare professionals to enhance awareness of stroke symptoms to help minimize its debilitating impact on the lives of survivors and their families is truly encouraging. This campaign win is a tribute to all of the focus and commitment to improved stroke care in India.”

In its committed efforts in the area of brain stroke, Boehringer Ingelheim India has established a partnership model to help hospitals across 23 States and 3 Union Territories to improve the standard of care for stroke management and collaborated with 380 centers enabling support for over 10,000 patients to access effective stroke care.

About Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com

Established in 2003, Boehringer Ingelheim India, manages the India and the neighboring markets operations of the global enterprise. The Company enables access to innovator products as part of its Human Pharma and Animal Health businesses. The focus Human Pharma therapy areas include diabetes, cardiovascular and respiratory conditions. www.boehringer-ingelheim.in

For further information, please contact –
Magline Rufina FR
Director – Communications, Boehringer Ingelheim India
Email: magline.rufina_f_r@boehringer-ingelheim.com

Shivani Srinivas
Archetype
E-mail: shivani.srinivas@archetype.co
Mob: +91 7208056250

¹Nobel L, Mayo NE, Hanley J, et al. MyRisk_Stroke Calculator: A personalized stroke risk assessment tool for the general population. J Clin Neurol. 2014;10:1-9.